Skip to content

Clinical trials

Phase 1 Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 1 Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20041
20054
20066
20074
20084
20096
20103
20117
20122
20136
20148
20159
20164
20172
20182
20203
20217
20223
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Terminated6
Unknown status5
Active, not recruiting3
Recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University16
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.7
Luye Pharma Group Ltd.6
Amgen3
Dartmouth-Hitchcock Medical Center3
New York State Psychiatric Institute3
Pakistan Institute of Living and Learning3
King's College London2
Mclean Hospital2
National Institute of Mental Health (NIMH)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders92
Schizophrenia68
Marijuana Abuse11
Bipolar Disorder9
Mood Disorders7
Mental Disorders5
Schizophrenia Spectrum and Other Psychotic Disorders5
Substance-Related Disorders3
Anxiety Disorders2
Depressive Disorder2

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.